艾灸机器人治疗原发性痛经的有效性与安全性:随机对照预试验
该随机对照预试验将70例原发性痛经患者分为艾灸机器人组和手动艾灸组,每组35例,取关元穴(CV4)进行艾灸热刺激,治疗3个月经周期并随访3个月经周期。结果显示两组SF-MPQ和CMSS评分均较基线显著下降(P<0.05),组间第3和第6个月经周期无显著差异(P>0.05);艾灸机器人组不良事件总发生率2.1%,显著低于手动艾灸组的7.2%(P<0.05)。结论认为艾灸机器人与手动艾灸疗效相当但更安全。
要点
- 艾灸机器人治疗原发性痛经的疗效与手动艾灸相当。
- 艾灸机器人不良事件总发生率2.1%,显著低于手动艾灸的7.2%。
- 两组SF-MPQ和CMSS评分均较基线显著下降(P<0.05)。
核心结论
- 艾灸机器人在改善原发性痛经患者SF-MPQ和CMSS评分方面与手动艾灸效果相同,但安全性优于手动艾灸。
研究设计与样本
- 采用计算机生成随机化的随机对照预试验,共纳入70例原发性痛经患者,艾灸机器人组35例,手动艾灸组35例。
- 选取关元穴(CV4)接受艾灸热刺激,两组分别接受3个月经周期的治疗(每日1次,每次5天),并随访3个月经周期。
主要发现
- 共62例完成试验,艾灸机器人组32例,手动艾灸组30例。
- 与基线相比,两组SF-MPQ和CMSS评分均显著下降(P<0.05)。
- 第3和第6个月经周期时,两组间SF-MPQ和CMSS评分无显著差异(P>0.05)。
- 艾灸机器人组不良事件总发生率为2.1%,显著低于手动艾灸组的7.2%(P<0.05)。
临床怎么用
- 艾灸机器人可作为原发性痛经的替代艾灸治疗方式,可能降低不良事件风险。
局限性
- 本研究为预试验,样本量较小,完成试验仅62例,结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To conduct a pilot trial to explore the effectiveness and safety of moxibustion robots in treating primary dysmenorrhea (PD) and evaluate its feasibility in clinic. METHODS: A total of 70 participants with PD were allocated to either moxibustion robot (MR) group (35 cases) or manual moxibustion (MM) group (35 cases) using computer-generated randomization. One acupoint Guanyuan (CV 4) was selected to receive moxa heat stimulation. Two groups of participants were given 3 menstrual cycles of MM and MR treatment respectively (once a day, 5 days a session) and received another 3 menstrual cycles follow-up. The degree of pain was evaluated by short-form McGill pain questionnaire (SF-MPQ) and the symptoms of dysmenorrhea were evaluated by Cox Menstrual Symptom Scale (CMSS). The safety was measured by the occurrence rate of adverse events (AEs), including burns (blisters, red and swollen), itching, bowel changes, menstrual cycle disorder, menorrhagia and fatigue, etc. RESULTS: A total of 62 patients completed the trial, 32 in MR group and 30 in MM group. Compared with baseline, scores of SF-MPQ and CMSS significantly decreased in both groups (P<0.05), and no significant difference was observed between the two groups in the 3rd and 6th menstrual cycles (P>0.05). The total occurrence rate of AEs in MR group was 2.1%, which was significantly lower than MM group (7.2%, P<0.05). CONCLUSIONS: MR has the same effect as MM at SF-MPQ and CMSS in patients with PD. However, MR is safer than MM (Trial registration No. ChiCTR1800018236).
引用
- Zhang HR, Tu HY, Wang Y, et al. Effectiveness and Safety of Moxibustion Robots on Primary Dysmenorrhea: A Randomized Controlled Pilot Trial. Chin J Integr Med. 2021. PMID: 33837481. doi:10.1007/s11655-021-3287-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。